Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in ANIK — Anika Therapeutics, Inc.

CIK 1167557 Greenwich, CT
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,190,545
+$4,242,645 QoQ
Shares Held
559,846
+105.6% QoQ
Ownership
4.18%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 134 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. ANIK ranks #17 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 3,818,037 $643,491,951
2 UTHR
UNITED THERAPEUTICS Corp
 546,002 $295,840,259
3 ZTS
Zoetis Inc.
 1,070,929 $76,956,955
4 VTRS
Viatris Inc
 4,694,966 $74,556,056
5 PRGO
PERRIGO Co plc
 3,480,666 $36,164,117
6 LNTH
Lantheus Holdings, Inc.
 261,250 $28,983,071
7 IRWD
Ironwood Pharmaceuticals Inc
 6,465,921 $27,221,524
8 TAK
Takeda Pharmaceutical Co Ltd
 1,525,686 $24,456,745

All Filings in ANIK

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,190,545 559,846
2026-03-31 $3,947,900 272,269
2025-12-31 $665,779 69,280
2025-09-30 $464,950 49,463
2025-06-30 $537,610 50,814
2025-03-31 $181,214 12,057
2024-09-30 $758,090 30,692
2024-06-30 $2,719,756 107,373
2024-03-31 $2,522,245 99,301
2023-12-31 $2,133,461 94,151
2023-09-30 $1,370,311 73,554
2023-06-30 $833,308 32,075
2023-03-31 $913,985 31,824
2022-12-31 $942,493 31,841
2022-09-30 $580,482 24,390
2022-06-30 $328,215 14,705
2020-09-30 $1,903,840 53,796
2020-06-30 $4,444,292 117,792
2020-03-31 $3,511,032 121,447